• DOI:10.1126/scitranslmed.aab2271
• Corpus ID: 206687974

Early infancy microbial and metabolic alterations affect risk of childhood asthma

@article{Arrieta2015EarlyIM,
  title={Early infancy microbial and metabolic alterations affect risk of childhood asthma},
  author={Marie Claire Arrieta and Leah T. Stiemsma and Pedro A. Dimitriu and Lisa M. Thorson and Shannon L. Russell and Sophie Yurist-Doutsch and Boris Kuzeljevic and Matthew J. Gold and Heidi M. Britton and Diana L Lefebvre and Padmaja Subbarao and Piush J Mandhane and Allan B Becker and Kelly M. McNagny and Malcolm R. Sears and Tobias R. Kollmann and William W. Mohn and Stuart E. Turvey and B. Brett Finlay},
  journal={Science Translational Medicine},
  year={2015},
  volume={7},
  pages={307ra152 - 307ra152}
}

• M. Arrieta, Leah T. Stiemsma, +16 authors B. Brett Finlay
• Published 30 September 2015
• Medicine, Biology
• Science Translational Medicine

Supplementing bacterial genera reduced in infants at high risk for asthma ameliorates lung inflammation in mice. Window of opportunity for asthma Changes in the gut microbiota have been implicated in the development of asthma in animal models; however, it has remained unclear whether these findings hold true in humans. Now, Arrieta et al. report in a longitudinal human study that infants at risk of asthma have transient gut microbial dysbiosis during the first 100 days of life. They found that certain bacterial genera were decreased in these children. Moreover, adding these bacteria back to germ-free mice decreased airway inflammation, suggesting a potential causative role of the loss of these microbes. They suggest a window where microbe-based diagnostics and therapeutics may be useful to prevent the development of asthma in high-risk individuals. Asthma is the most prevalent pediatric chronic disease and affects more than 300 million people worldwide. Recent evidence in mice has identified a “critical window” early in life where gut microbial changes (dysbiosis) are most influential in experimental asthma. However, current research has yet to establish whether these changes precede or are involved in human asthma. We compared the gut microbiota of 319 subjects enrolled in the Canadian Healthy Infant Longitudinal Development (CHILD) Study, and show that infants at risk of asthma exhibited transient gut microbial dysbiosis during the first 100 days of life. The relative abundance of the bacterial genera Lachnospira, Veillonella, Faecalibacterium, and Rothia was significantly decreased in children at risk of asthma. This reduction in bacterial taxa was accompanied by reduced levels of fecal acetate and dysregulation of enterohepatic metabolites. Inoculation of germ-free mice with these four bacterial taxa ameliorated airway inflammation in their adult progeny, demonstrating a causal role of these bacterial taxa in averting asthma development. These results enhance the potential for future microbe-based diagnostics and therapies, potentially in the form of probiotics, to prevent the development of asthma and other related allergic diseases in children.